Top Ten Healthcare Stocks on FTSE – NMC, MDC, MCS, IDHC, SPI, CTH, MDMG, MER, MGP and ONC

 NMC Health Plc

NMC Health Plc (LON: NMC) is a London; the United Kingdom based Healthcare equipment as well as service provider company that mainly operates in the region of United Arab Emirates. The company’s business is divided into two divisions which are Healthcare division and the Distribution services division. The company specialises in providing all kinds of healthcare and medical services through its hospitals

NMC Share Price Performance

On 29th November 2019, at 09:00 A.M GMT, at the time of writing, NMC Health Plc’s share price was reported to be at GBX 2506.00 per share, a decline of 2.49 per cent or GBX 64.00 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 2570.00 per share.  The market capitalisation of the company has been reported to be at a value of GBP 5.368 billion with respect to the share’s current market price. The beta of the NMC Health Plc’s share has been reported to be at 0.98.

 

Mediclinic International Plc

Mediclinic International Plc (LON: MDC) is a London, the United Kingdom based company that engages in the supply of healthcare equipment and services around the globe. The company was founded in the year 1983 and is headquartered in Stellenbosch, South Africa. The company operates internationally with Switzerland, Namibia, South Africa and the United Arab Emirates being the main markets.

MDC Share Price Performance

On 29th November 2019, at 09:07 A.M GMT, at the time of writing, Mediclinic International Plc’s share price was reported to be at GBX 392.70 per share, a decline of 1.48 per cent or GBX 5.90 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 398.60 per share.  The market capitalisation of the company has been reported to be at a value of GBP 2.938 billion with respect to the share’s current market price. The beta of the Mediclinic International Plc’s share has been reported to be at 1.32.

McCarthy and Stone Plc

McCarthy and Stone Plc (LON: MCS) is a company located in the Southern Coast of England, near Bournemouth. It is a house developer, specifically for the purposes of retirement residential development with a range of care and support services. The company trades in the name of Ortus Homes.

MCS Share Price Performance

On 29th November 2019, at 09:18 A.M GMT, At the time of writing, McCarthy and Stone Plc’s share price was reported to be trading at GBX 140.45 per share, a decrease of 0.60 per cent or GBX 0.848 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 141.30 per share. The market capitalisation of the company has been reported to be at a value of GBP 759.25 million with respect to the share’s current market price. The beta of the McCarthy and Stone Plc’s share has been reported to be at -0.17.

Integrated Diagnostic Holdings Plc

Integrated Diagnostic Holdings Plc (LON: IDHC) is a Saint Helier, Jersey based Healthcare equipment and services company that majorly operates in the Middle Eastern and African region and provides diagnostic services to various medical organisations. These services span from immunology and microbiology to Radiology and Molecular biology.

IDHC Share Price Performance

On 29th November 2019, at 09:45 A.M GMT, at the time of writing, Integrated Diagnostic Holdings Plc’s share price was reported to be at GBX 4.65 per share, an increase of 0.22 per cent or GBX 0.01 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 4.64 per share.  The market capitalisation of the company has been reported to stand at a value of GBP 539.41 million with respect to the share’s current market price. The beta of the Integrated Diagnostic Holdings Plc’s share has been reported to be at 0.16.

Spire Healthcare Group Plc

Spire Healthcare Group Plc (LON: SPI) is a London, the United Kingdom based company that engages in the operations of hospitals and other healthcare providing institutions. Apart from running a chain of independently run hospitals, the company also engages in specialised treatment as well as medical consulting.

SPI Share Price Performance

On 29th November 2019, at 09:50 A.M GMT, at the time of writing, Spire Healthcare Group Plc’s share price was reported to be at GBX 122.70 per share, a decline of 1.45 per cent or GBX 1.80 per share, in comparison with the stock price, at the time of closing on the previous day, which was reported to be at GBX 124.50 per share.  The market capitalisation of the company has been reported to be at a value of GBP 499.35 million with respect to the share’s current market price. The beta of the Spire Healthcare Group Plc’s share has been reported to be at 1.33.

Comparative Share Price Chart of NMC, MDC, MCS, IDHC and SPI

(Source: Thomson Reuters) Daily Chart as on 29-November-19, prior to the close of the market

Caretech Holdings Plc

Caretech Holdings Plc (LON: CTH) is a Potters Bar; the United Kingdom based Social Healthcare equipment and services provider. The company provides a wide variety of special care social services for both children and young people and adults.

CTH Share Price Performance

On 29th November 2019, at 10:00 A.M GMT, at the time of writing, Caretech Holdings Plc’s share price was reported to be trading at GBX 380.00 per share, no change in comparison with the stock price, at the time of closing in the previous session.  The market capitalisation of the company has been reported to be at a value of GBP 424.43 million with respect to the share’s current market price. The beta of the Caretech Holdings Plc’s share has been reported to be at 0.2277.

MD Medical Group Investments Plc

MD Medical Group Investments Plc (LON: MDMG) is a Nicosia, Cyprus based healthcare company that owns around 39 medical centres and hospitals across 26 cities in the Russian Federation and Eastern Europe. It has the distinction of being the only Russian healthcare organisations which successfully floated an Initial Public Offering on London bourse.

MDMG Share Price Performance

On 29th November 2019, at 10:05 A.M GMT, at the time of writing, MD Medical Group Investments Plc’s share price was reported to be at GBX 4.84 per share, a decline of 0.41 per cent or GBX 0.02 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 4.84 per share.  The market capitalisation of the company has been reported to stand at a value of GBP 282.96 million with respect to the share’s current market price. The beta of the MD Medical Group Investments Plc’s share has been reported to be at 1.10.

Mears Group Plc

Mears Group Plc (LON: MER) is a Gloucester; the United Kingdom based Healthcare support services company that provides Nursing, as well as outcome-based care services and Reablement services to its clients based in the vicinity of the country through its various housing as well as senior centres.

MER Share Price Performance

On 29th November 2019, at 10:15 A.M GMT, at the time of writing, Mears Group Plc’s share price was reported to be at GBX 246.09 per share, a decline of 0.37 per cent or GBX 0.91 per share, in comparison with the stock price, at the time of closing in the previous session, which was reported to be at GBX 247.00 per share. The market capitalisation of the company has been reported to stand at a value of GBP 272.91 million with respect to the share’s current market price. The beta of the Mears Group Plc’s share has been reported to be at 0.07.

Medica Group Plc

Medica Group plc (LON: MGP) is the United Kingdom domiciled healthcare services company that operates in the Biotech and radiology space and provides services like Routine reporting, Specialist services, audit services, Radiographer reporting as well as late-night services.

MGP Share Price Performance

On 29th November 2019, at 10:25 A.M GMT, at the time of writing, Medica Group Plc’s share price was reported to be at GBX 142.00 per share, no change in comparison with the stock price, at the time of closing in the previous session.  The market capitalisation of the company has been reported to stand at a value of GBP 157.78 million with respect to the share’s current market price.

Oncimmune Holdings Plc

Oncimmune Holdings Plc (LON: ONC) is a Nottingham, the United Kingdom based Pharmaceuticals and Biotechnology company that engages in the research and diagnosis around Cancer. The company’s research has proven to be extremely successful with them being able to diagnose early-stage cancer with Lung Cancer Blood Test, Liver Cancer Blood Test, through its SeroTag Platform as well as its product called NavigAid.

ONC Share Price Performance

On 29th November 2019, at 11:40 A.M GMT, at the time of writing, Oncimmune Holdings Plc’s share price was reported to be at GBX 50.00 per share, a decrease of 0.99 per cent or GBX 0.50 per share in the stock price, as compared to GBX 50.50, the price at the time of closing in the previous session. The market capitalisation of the company has been reported to stand at a value of GBP 31.94 million with respect to the share’s current market price. The beta of the Oncimmune Holdings Plc’s share has been reported to be at -0.41.

Comparative Share Price Chart of CTH, MDMG, MER, MGP and ONC

(Source: Thomson Reuters) Daily Chart as on 29-November-19, prior to the close of the market